Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$1.9B
Avg Funding
$77.7M
Global Reach
8
countries

Top Cities for Biopharma

Mount Waverley
San Diego
New York
La Jolla
Cambridge
Santa Monica

Recently Funded Companies

Export
Mount Waverley, Australia

Cann Group is a developer and supplier of cannabis, cannabis resin and medicinal cannabis products into the market.

$533K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

$16.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

$60.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

$35.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

$550.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Santa Monica, United States

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

$13.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

New Haven, United States

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

$8.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

$719.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

$5.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

$10.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

Steer Bio is a biotechnology company that specializes in revitalizing cell-based medicines.

$18.2M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland

Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.

$3.8M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

$100.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Frederiksberg, Denmark

Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.

$1.5M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.

$15.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Freehold, United States

Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.

$9.8M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Henderson, United States

Zura Bio is a clinical-stage, multi-asset biotechnology company.

$144.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

$150.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Budapest, Hungary

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

$25.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden

Technologies for the next generation of antibody therapies.

Feb 2026

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.

$2.4M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Ithaca, United States

Protogenix is developing a novel platform for protein production to replace the mammalian system.

$250K raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Palm Beach, United States

Jupiter Biomedical Research is a company that offers commercial services.

$500K raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

$40.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Lille, France

4Moving Biotech is a biopharmaceutical company that develops osteoarthritis drugs for osteoarthritis patients.

$14.3M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Showing 176 to 200 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$77.7M
Total Funding Tracked
$1.9B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
3 companies$800.0M
2.Waltham
2 companies$759.0M
3.Mount Waverley
1 companies$533K
4.San Diego
1 companies$16.1M
5.New York
1 companies$60.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked